ASAIO journal (American Society for Artificial Internal Organs : 1992) · 2025
Incidence and Risk Factors of Cannula-Associated Deep Vein Thrombosis After Extracorporeal Life Support in Adult Critically Ill Patients.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Almoosawy Sayed Abdulmotaleb, Albalool Joud, Alenezi Ahmad, Murad Anwar, Buabbas Sarah, Almutawa Abdulaziz, Abdulmalek Kefaya, Al-Fares Abdulrahman
Аннотация
Cannula-associated deep vein thrombosis (CaDVT) following decannulation from extracorporeal life support (ECLS) is a commonly reported complication with several associated risk factors. This study investigated the incidence and risk factors of CaDVT after ECLS decannulation from a nationwide registry. We analyzed consecutive patients who were successfully decannulated from ECLS and screened for CaDVT from two medical-surgical intensive care units (ICU) in Kuwait between 2016 and 2023. The incidence of CaDVT was assessed and correlated with risk factors such as baseline characteristics, ECLS mode and duration, and cannula sizes. Length of stay (LOS) in the ICU, along with ICU and in-hospital mortality were reported. Of 403 patients supported with ECLS, 144 underwent postdecannulation ultrasound. Cannula-associated deep vein thrombosis occurred in 94 (65%) patients. Venovenous ECLS (V-V ECLS) was the only independent risk factor associated with post-ECLS CaDVT (odds ratio [OR]: 4.78; 95% confidence interval [CI]: 1.18-19.4). Length of stay in the ICU and mortality were similar between patients with and without CaDVT. Cannula-associated deep vein thrombosis is a frequent complication of ECLS, occurring in more than half of patients. The use of V-V ECLS appears to be an independent risk factor for the development of post-ECLS CaDVT. Further efforts are needed to develop formal recommendations for screening and managing CaDVT post-ECLS.